Author

Silvia Menegatti

InsermORCID 0000-0002-8155-9169Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Jaime R. FuentealbaiD· 2 shared Amaury LerusteiD· 1 shared Ana Inés LalanneiD· 1 shared Aude BattistellaiD· 1 shared Aurélie DarboisiD· 1 shared Camille JametiD· 1 shared Cécile ConradiD· 1 shared Céline Collin· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Jaime R. FuentealbaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Specific killing of Ewing sarcoma by TCR-T cells targeting public neogene-encoded antigens

Ana Inés Lalanne, Céline Collin, Floriane Petit, Mégane Lacaud, Yago A. Arribas, Aurélie Darbois, Amaury Leruste, Maria K. Koshkina, Kyle A. Raymond, Paul Klein, Julien Vibert, Sakina Zaïdi, Sandrine Grossetête, Jill Pilet, Karine Laud-Duval, , Olivier Delattre

The paper demonstrates that TCR-T cells targeting neogene-encoded antigens can specifically kill Ewing sarcoma cells in vitro and in vivo.

bioRxiv · Jun 25, 2026 · PreprintImmunology

The DivisionCounter, a method for counting large ranges of cell divisions in vivo, reveals cell dynamics of leukemic cell killing via CAR-T therapy

Lucie S P Hustin, Cécile Conrad, Chang Liu, Jaime R. Fuentealba, Silvia Menegatti, Seva Shneer, Aude Battistella, Fanny Tabarin, Tom S Weber, Sebastián Amigorena, Ken R. Duffy, Leïla Perié

The paper introduces DivisionCounter, a method to count large cell divisions in vivo, showing leukemia tumor division rates are independent of microenvironment and CAR-T treatment.

bioRxiv · Jun 24, 2024 · PreprintImmunology